Skip to main content

What Did You Miss?

Published: 2/28/22
By Matthew Garza

In case you missed them, below you’ll find our top five stories from February 2022. This month’s best stories cover a wide variety of topics including diet recommendations, the launch of a new online resource for combating diabetes stigma, and new type 1 cures research.

1. Omnipod 5 Cleared by the FDA

The Omnipod 5 automated insulin delivery system has been cleared by the FDA for people with type 1 diabetes. The system, which includes a tubeless insulin pump, a Dexcom G6 continuous glucose monitor, and a smartphone app, will be available later in 2022.

2. ViaCyte and CRISPR Introduce New Stem Cell Therapy for Type 1 Diabetes

In a collaboration between ViaCyte and CRISPR Therapeutics, a new clinical trial is investigating a stem cell therapy that may eventually help millions with type 1 diabetes.

3. Mediterranean Diet Voted Best for 2022: What Do Diabetes Experts Say?

The Mediterranean Diet has once again been recognized as one of the best overall. What makes it so special? How can you integrate some of its features into what you are currently eating? We spoke with nutritionists to find out more about how you can benefit from this eating plan.

4. Which Type of Exercise Is Best for Managing Diabetes, Aerobic Exercise or Weightlifting?

What are the different types of exercise and how do they affect your glucose levels? 

5. dStigmatize: Ending Diabetes Stigma

diaTribe is launching a new website, dStigmatize.org, to provide a comprehensive resource for understanding, reducing, and ending diabetes stigma. Reducing diabetes stigma starts with education and advocacy.

What do you think?

About the authors

Matthew Garza joined the diaTribe Foundation as an associate in 2020 where he worked on diaTribe Learn and the dSeries Executive Innovation Labs. In February 2022, he helped launch dStigmatize.org... Read the full bio »